Late-term hospitalization of mares with high-risk pregnancies warranted - study
Mare previously assessed as high-risk were found to have significantly more delivery problems than normal.
Source: horsetalk.co.nz
Page 7 - Retrospective Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Retrospective Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Retrospective Study Today - Breaking & Trending Today
Global Blood Therapeutics, Inc.: GBT Presents Positive New Real-World Evidence Data at EHA2022 Congress Further Supporting Clinical Use of Oxbryta (voxelotor) in Sickle Cell Disease
Positive results from Phase 1 study of GBT601, including incremental new data, support advancing into planned Phase 2/3 trial by mid-year GBT to hold investor conference call and webcast today at 3:00
Source: finanznachrichten.de
Investegate |Global Blood Therapeutics, Inc Announcements | Global Blood Therapeutics, Inc: GBT Presents Positive New Real-World Evidence Data at EHA2022 Congress Further Supporting Clinical Use of Oxbryta® (voxelotor) in Sickle Cell Disease
Investegate announcements from Global Blood Therapeutics, Inc, GBT Presents Positive New Real-World Evidence Data at EHA2022 Congress Further Supporting Clinical Use of Oxbryta® (voxelotor) in Sickle Cell Disease
Source: investegate.co.uk
GBT Announces Five Data Presentations on Sickle Cell Disease at Upcoming EHA2022 Congress
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
GBT Announces Five Data Presentations on Sickle Cell
New real-world evidence data on Oxbryta® (voxelotor) from multicenter RETRO Study and new Phase 1 data on GBT601 to be highlighted SOUTH SAN FRANCISCO,...
Source: globenewswire.com